Pharnext (France) Performance
| ALPHA Stock | EUR 0.0002 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pharnext are completely uncorrelated. Pharnext SA right now holds a risk of 0.0%. Please check Pharnext SA accumulation distribution and price action indicator , to decide if Pharnext SA will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Pharnext SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Pharnext is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 11.1 M | |
| Total Cashflows From Investing Activities | 26 K |
Pharnext |
Pharnext Relative Risk vs. Return Landscape
If you would invest 0.02 in Pharnext SA on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Pharnext SA or generate 0.0% return on investment over 90 days. Pharnext SA is generating negative expected returns and assumes 0.0% volatility on return distribution over the 90 days horizon. Simply put, 0% of stocks are less volatile than Pharnext, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pharnext Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharnext's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharnext SA, and traders can use it to determine the average amount a Pharnext's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ALPHA |
Based on monthly moving average Pharnext is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharnext by adding Pharnext to a well-diversified portfolio.
Pharnext Fundamentals Growth
Pharnext Stock prices reflect investors' perceptions of the future prospects and financial health of Pharnext, and Pharnext fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharnext Stock performance.
| Return On Equity | -13.48 | |||
| Return On Asset | -0.76 | |||
| Operating Margin | (9.13) % | |||
| Current Valuation | 20.06 M | |||
| Shares Outstanding | 875.25 M | |||
| Price To Book | 24.54 X | |||
| Price To Sales | 0.1 X | |||
| Revenue | 84.78 K | |||
| EBITDA | (26.57 M) | |||
| Cash And Equivalents | 18.17 M | |||
| Cash Per Share | 1.51 X | |||
| Total Debt | 13.2 M | |||
| Book Value Per Share | (678.99) X | |||
| Cash Flow From Operations | (23.73 M) | |||
| Earnings Per Share | (4,500) X | |||
| Total Asset | 16.45 M | |||
About Pharnext Performance
Assessing Pharnext's fundamental ratios provides investors with valuable insights into Pharnext's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Pharnext is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Pharnext SA, a clinical-stage biopharmaceutical company, develops therapeutics for severe orphan and common neurodegenerative diseases in France. The company was founded in 2007 and is based in Issy-Les-Moulineaux, France. Pharnext S is traded on Paris Stock Exchange in France.Things to note about Pharnext SA performance evaluation
Checking the ongoing alerts about Pharnext for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharnext SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharnext SA generated a negative expected return over the last 90 days | |
| Pharnext SA has some characteristics of a very speculative penny stock | |
| Pharnext SA has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 84.78 K. Net Loss for the year was (30.62 M) with profit before overhead, payroll, taxes, and interest of 3.56 M. | |
| Pharnext SA has accumulated about 18.17 M in cash with (23.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Pharnext's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharnext's stock is overvalued or undervalued compared to its peers.
- Examining Pharnext's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharnext's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharnext's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharnext's stock. These opinions can provide insight into Pharnext's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pharnext Stock Analysis
When running Pharnext's price analysis, check to measure Pharnext's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharnext is operating at the current time. Most of Pharnext's value examination focuses on studying past and present price action to predict the probability of Pharnext's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharnext's price. Additionally, you may evaluate how the addition of Pharnext to your portfolios can decrease your overall portfolio volatility.